Neuropilin-1 facilitates SARS-CoV2 cell entry and infectivity | |||||
Thu19 Dec11:00am(30 mins)
|
Dr Maria Anastasina | ||||
Session : New Approaches in Infection Biology | |||||
Room: Room 3A |
Functional analysis of Bartonella pathogenicity factors might contribute to novel therapeutic concepts | |||||
Thu19 Dec12:00pm(30 mins)
|
Prof Volkhard Kempf | ||||
Session : New Approaches in Infection Biology | |||||
Room: Room 3A |
Targeting the human RED-SMU1 splicing complex as a basis for host-directed anti-influenza therapy | |||||
Thu19 Dec02:00pm(30 mins)
|
Dr Nadia Naffakh | ||||
Session : New Approaches in Infection Biology | |||||
Room: Room 3A |
Introducing TRFID, a UK-leading BSL3 translation biology facility for Infectious Diseases at Alderley Park | |||||
Thu19 Dec02:30pm(5 mins)
|
Dr Helen Bright | ||||
Session : New Approaches in Infection Biology | |||||
Room: Room 3A |
LabLogic Life Sciences range has something for everyone | |||||
Thu19 Dec02:35pm(5 mins)
|
Lucy Farmer | ||||
Session : New Approaches in Infection Biology | |||||
Room: Room 3A |
FidaBio: Characterizing Biomolecular behaviour by measuring and monitoring changes in hydrodynamic radius | |||||
Thu19 Dec02:40pm(5 mins)
|
Jo Walter | ||||
Session : New Approaches in Infection Biology | |||||
Room: Room 3A |
Studies of the membrane-bound pyrophosphatase as a potential drug target against protist parasites | |||||
Thu19 Dec02:45pm(30 mins)
|
Dr Keni Vidilaseris | ||||
Session : New Approaches in Infection Biology | |||||
Room: Room 3A |
Developing inhibitors that block adhesin-collagen interactions | |||||
Thu19 Dec03:45pm(30 mins)
|
Prof Dirk Linke | ||||
Session : New Approaches in Infection Biology | |||||
Room: Room 3A |
PerkinElmer’s Tools to study virus-host interaction and virus inhibition | |||||
Thu19 Dec04:15pm(15 mins)
|
Dr Louise Affleck | ||||
Session : New Approaches in Infection Biology | |||||
Room: Room 3A |